Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6201
PUT
Toro Company
TTC
$9.37B
| $1.24M | ﹤0.01% |
13,100
-9,400
| -42% | -$831K |
|
6202
Zions Bancorporation
ZION
$10.5B
| $1.24M | ﹤0.01% |
28,571
-276,274
| -91% | -$10.2M |
|
6203
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$292M
| $1.24M | ﹤0.01% |
36,598
-179,142
| -83% | -$5.69M |
|
|
AAN
6204
DELISTED
The Aaron's Company Inc
AAN
| $1.24M | ﹤0.01% |
+65,404
| New | +$1.2M |
|
6205
CALL
Pegasystems
PEGA
$5.19B
| $1.24M | ﹤0.01% |
18,600
-6,200
| -25% | -$395K |
|
6206
PUT
Allison Transmission
ALSN
$10.5B
| $1.24M | ﹤0.01% |
28,700
+17,100
| +147% | +$688K |
|
|
RDUS
6207
CALL
DELISTED
Radius Recycling
RDUS
| $1.24M | ﹤0.01% |
38,800
+12,800
| +49% | +$315K |
|
6208
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.41B
| $1.24M | ﹤0.01% |
+24,038
| New | +$1.24M |
|
6209
ProShares UltraPro MidCap400
UMDD
$35.8M
| $1.24M | ﹤0.01% |
60,690
-8,990
| -13% | -$143K |
|
6210
PUT
Haemonetics
HAE
$4.05B
| $1.24M | ﹤0.01% |
10,400
+4,200
| +68% | +$452K |
|
6211
PUT
Opko Health
OPK
$1.02B
| $1.24M | ﹤0.01% |
312,600
+26,900
| +9% | +$112K |
|
6212
VanEck Pharmaceutical ETF
PPH
$975M
| $1.24M | ﹤0.01% |
18,578
-45,035
| -71% | -$2.89M |
|
|
LMNX
6213
CALL
DELISTED
Luminex Corp
LMNX
| $1.24M | ﹤0.01% |
53,400
+10,600
| +25% | +$246K |
|
6214
Innovator US Equity Power Buffer ETF August
PAUG
$981M
| $1.23M | ﹤0.01% |
+43,613
| New | +$1.21M |
|
6215
CALL
United States Gasoline Fund
UGA
$142M
| $1.23M | ﹤0.01% |
50,700
-12,100
| -19% | -$252K |
|
6216
E.W. Scripps
SSP
$296M
| $1.23M | ﹤0.01% |
80,583
-61,468
| -43% | -$756K |
|
6217
PUT
Kodak
KODK
$967M
| $1.23M | ﹤0.01% |
151,200
-22,300
| -13% | -$186K |
|
6218
Lindblad Expeditions
LIND
$2.15B
| $1.23M | ﹤0.01% |
71,932
-38,167
| -35% | -$437K |
|
|
EVRI
6219
CALL
DELISTED
Everi Holdings
EVRI
| $1.23M | ﹤0.01% |
89,100
-5,800
| -6% | -$63K |
|
|
RUTH
6220
PUT
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $1.23M | ﹤0.01% |
69,300
+300
| +0.4% | +$4.21K |
|
6221
CALL
BioCryst Pharmaceuticals
BCRX
$2.55B
| $1.23M | ﹤0.01% |
164,800
-5,100
| -3% | -$26.3K |
|
6222
Aptus Defined Risk ETF
DRSK
$1.53B
| $1.23M | ﹤0.01% |
41,834
+34,905
| +504% | +$1.05M |
|
6223
CALL
Enovis
ENOV
$1.42B
| $1.23M | ﹤0.01% |
18,650
-2,092
| -10% | -$122K |
|
6224
PUT
Silgan Holdings
SLGN
$4.42B
| $1.23M | ﹤0.01% |
+33,100
| New | +$1.19M |
|
6225
CALL
ACI Worldwide
ACIW
$5.26B
| $1.23M | ﹤0.01% |
31,900
+3,100
| +11% | +$104K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.